Artikler med mandater om offentlig tilgang - David H. RAULETLes mer
Tilgjengelige et eller annet sted: 72
Innate or adaptive immunity? The example of natural killer cells
E Vivier, DH Raulet, A Moretta, MA Caligiuri, L Zitvogel, LL Lanier, ...
science 331 (6013), 44-49, 2011
Mandater: US National Institutes of Health, Howard Hughes Medical Institute, National …
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
N Guerra, YX Tan, NT Joncker, A Choy, F Gallardo, N Xiong, S Knoblaugh, ...
Immunity 28 (4), 571-580, 2008
Mandater: US National Institutes of Health
Regulation of ligands for the NKG2D activating receptor
DH Raulet, S Gasser, BG Gowen, W Deng, H Jung
Annual review of immunology 31 (1), 413-441, 2013
Mandater: US National Institutes of Health
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
J Hsu, JJ Hodgins, M Marathe, CJ Nicolai, MC Bourgeois-Daigneault, ...
The Journal of clinical investigation 128 (10), 4654-4668, 2018
Mandater: US National Institutes of Health, Canadian Cancer Society, Canadian …
Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response
A Marcus, AJ Mao, M Lensink-Vasan, LA Wang, RE Vance, DH Raulet
Immunity 49 (4), 754-763. e4, 2018
Mandater: US National Institutes of Health, Howard Hughes Medical Institute
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
DH Raulet, N Guerra
Nature Reviews Immunology 9 (8), 568-580, 2009
Mandater: US National Institutes of Health
Neutrophils suppress intraluminal NK cell–mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells
A Spiegel, MW Brooks, S Houshyar, F Reinhardt, M Ardolino, E Fessler, ...
Cancer discovery 6 (6), 630-649, 2016
Mandater: US National Institutes of Health, Human Frontier Science Program
Recognition of tumors by the innate immune system and natural killer cells
A Marcus, BG Gowen, TW Thompson, A Iannello, M Ardolino, W Deng, ...
Advances in immunology 122, 91-128, 2014
Mandater: US National Institutes of Health
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
A Iannello, TW Thompson, M Ardolino, SW Lowe, DH Raulet
Journal of Experimental Medicine 210 (10), 2057-2069, 2013
Mandater: US National Institutes of Health, Canadian Institutes of Health Research
NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model
NT Joncker, NC Fernandez, E Treiner, E Vivier, DH Raulet
The Journal of Immunology 182 (8), 4572-4580, 2009
Mandater: US National Institutes of Health
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
NK Wolf, DU Kissiov, DH Raulet
Nature Reviews Immunology 23 (2), 90-105, 2023
Mandater: US National Science Foundation, US National Institutes of Health
SLC19A1 transports immunoreactive cyclic dinucleotides
RD Luteijn, SA Zaver, BG Gowen, SK Wyman, NE Garelis, L Onia, ...
Nature 573 (7774), 434-438, 2019
Mandater: US National Institutes of Health
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
NT Joncker, N Shifrin, F Delebecque, DH Raulet
Journal of Experimental Medicine 207 (10), 2065-2072, 2010
Mandater: US National Institutes of Health
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
W Deng, BG Gowen, L Zhang, L Wang, S Lau, A Iannello, J Xu, TL Rovis, ...
Science 348 (6230), 136-139, 2015
Mandater: US National Institutes of Health
NK cell self tolerance, responsiveness and missing self recognition
N Shifrin, DH Raulet, M Ardolino
Seminars in immunology 26 (2), 138-144, 2014
Mandater: US National Institutes of Health
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists
CJ Nicolai, N Wolf, IC Chang, G Kirn, A Marcus, CO Ndubaku, ...
Science immunology 5 (45), eaaz2738, 2020
Mandater: US National Institutes of Health
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
M Ardolino, CS Azimi, A Iannello, TN Trevino, L Horan, L Zhang, W Deng, ...
The Journal of clinical investigation 124 (11), 4781-4794, 2014
Mandater: US National Institutes of Health
Regulation of NK cell responsiveness to achieve self‐tolerance and maximal responses to diseased target cells
NT Joncker, DH Raulet
Immunological reviews 224 (1), 85-97, 2008
Mandater: US National Institutes of Health
RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma
AR Lam, N Le Bert, SSW Ho, YJ Shen, MLF Tang, GM Xiong, JL Croxford, ...
Cancer research 74 (8), 2193-2203, 2014
Mandater: US National Institutes of Health
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
H Jung, B Hsiung, K Pestal, E Procyk, DH Raulet
Journal of Experimental Medicine 209 (13), 2409-2422, 2012
Mandater: US National Institutes of Health
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram